Filing Details
- Accession Number:
- 0001209191-23-037613
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-06-15 21:00:29
- Reporting Period:
- 2023-06-13
- Accepted Time:
- 2023-06-15 21:00:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1863127 | Tyra Biosciences Inc. | TYRA | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1711463 | Todd Harris | C/O Tyra Biosciences, Inc. 2656 State Street Carlsbad CA 92008 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-06-13 | 7,927 | $2.25 | 1,709,203 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-06-13 | 7,927 | $16.00 | 1,701,276 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-06-15 | 12,773 | $2.25 | 1,714,049 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-06-15 | 12,773 | $16.13 | 1,701,276 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2023-06-13 | 7,927 | $0.00 | 7,927 | $2.25 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2023-06-15 | 12,773 | $0.00 | 12,773 | $2.25 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 389,610 | 2031-03-09 | No | 4 | M | Direct | |
| 376,837 | 2031-03-09 | No | 4 | M | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in March 2022.
- Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.05. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.60. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- 1/48th of the shares subject to the option vest monthly following March 5, 2021, the vesting commencement date.
Billionaire Hedge Funds
